Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2017

01-10-2017 | Breast Oncology

Breast Cancer Disparities: Socioeconomic Factors versus Biology

Author: Lisa A. Newman, MD, MPH

Published in: Annals of Surgical Oncology | Issue 10/2017

Login to get access

Abstract

Disparities in poverty and health care access barriers have a negative impact on the health and wellness of population subsets that bear a disproportionate share of these socioeconomic disadvantages, such as African Americans and Hispanic/Latina Americans. The more advanced stage distribution of breast cancer in these two population subsets is likely related to imbalance in distribution of socioeconomic resources in the United States. However, differences in the breast cancer burden of population subsets defined by racial/ethnic identity are also influenced by race/ethnicity-associated variation in tumor biology and hereditary susceptibility. Compared with white Americans, African-American women have higher population-based breast cancer mortality rates, which are at least partly explained by an increased risk for the biologically aggressive triple-negative phenotype. International studies correlate West African ancestry with predisposition for triple-negative breast cancer. In contrast, Hispanic/Latina Americans have lower population-based incidence and mortality rates for breast cancer despite their increased rates of socioeconomic challenges. Genetic studies suggest that extent of Native American ancestry among Hispanic/Latina women may reduce breast cancer risk. Eradication of disparate access to breast cancer early detection and treatment strategies is a public health imperative, but research to elucidate the genetics of breast cancer related to racial/ethnic identity is equally important as we strive to comprehensively define this complex disease.
Literature
4.
go back to reference Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.CrossRefPubMed Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.CrossRefPubMed
6.
go back to reference Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and Hispanic groups by state and place: 2007–2011; American Community Survey Briefs. In: U.S. Department of Commerce EaSA, ed. American Community Series Brief/11–17: U.S. Census Bureau, census.gov; 2013. Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and Hispanic groups by state and place: 2007–2011; American Community Survey Briefs. In: U.S. Department of Commerce EaSA, ed. American Community Series Brief/1117: U.S. Census Bureau, census.gov; 2013.
7.
go back to reference DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42.CrossRefPubMed DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42.CrossRefPubMed
8.
go back to reference Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24(9):1342–49.CrossRefPubMed Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24(9):1342–49.CrossRefPubMed
9.
go back to reference Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101(14):984–92.CrossRefPubMedPubMedCentral Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101(14):984–92.CrossRefPubMedPubMedCentral
10.
go back to reference Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975–2011, Featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048. Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975–2011, Featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.
11.
go back to reference Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017;152(5):485–93.CrossRefPubMed Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017;152(5):485–93.CrossRefPubMed
12.
go back to reference Fejerman L, Ahmadiyeh N, Hu D, et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nature Comm. 2014;5:5260.CrossRef Fejerman L, Ahmadiyeh N, Hu D, et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nature Comm. 2014;5:5260.CrossRef
13.
go back to reference Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.CrossRefPubMed Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.CrossRefPubMed
15.
go back to reference Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society, Inc. 2015. Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society, Inc. 2015.
16.
go back to reference Chen L, Li CI. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1666–72.CrossRefPubMedPubMedCentral Chen L, Li CI. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1666–72.CrossRefPubMedPubMedCentral
17.
go back to reference Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.CrossRefPubMed Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.CrossRefPubMed
18.
go back to reference Rizzo M, Lund MJ, Mosunjac M, et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer. 2009;115(13):3009–15.CrossRefPubMed Rizzo M, Lund MJ, Mosunjac M, et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer. 2009;115(13):3009–15.CrossRefPubMed
19.
go back to reference Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst. 2008;100(7):462–74.CrossRefPubMed Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst. 2008;100(7):462–74.CrossRefPubMed
20.
go back to reference Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg. 2014;149(8):788–96.CrossRefPubMed Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg. 2014;149(8):788–96.CrossRefPubMed
21.
go back to reference Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23(27):6639–46.CrossRefPubMed Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23(27):6639–46.CrossRefPubMed
22.
go back to reference Magai C, Consedine NS, Adjei BA, Hershman D, Neugut A. Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention. Health Educ Behav. 2008;35(6):835–54.CrossRefPubMed Magai C, Consedine NS, Adjei BA, Hershman D, Neugut A. Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention. Health Educ Behav. 2008;35(6):835–54.CrossRefPubMed
23.
go back to reference Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31–36.CrossRefPubMed Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31–36.CrossRefPubMed
24.
go back to reference Reyes SA, King TA, Fei K, Franco R, Bickell NA. Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer. Ann Surg Oncol. 2016;23(5):1537–42.CrossRefPubMed Reyes SA, King TA, Fei K, Franco R, Bickell NA. Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer. Ann Surg Oncol. 2016;23(5):1537–42.CrossRefPubMed
25.
go back to reference Connors SK, Goodman MS, Myckatyn T, Margenthaler J, Gehlert S. Breast reconstruction after mastectomy at a comprehensive cancer center. Springerplus. 2016;5(1):955.CrossRefPubMedPubMedCentral Connors SK, Goodman MS, Myckatyn T, Margenthaler J, Gehlert S. Breast reconstruction after mastectomy at a comprehensive cancer center. Springerplus. 2016;5(1):955.CrossRefPubMedPubMedCentral
26.
go back to reference Sisco M, Du H, Warner JP, Howard MA, Winchester DP, Yao K. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg. 2012;215(5):658–66, discussion 666.CrossRefPubMed Sisco M, Du H, Warner JP, Howard MA, Winchester DP, Yao K. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg. 2012;215(5):658–66, discussion 666.CrossRefPubMed
27.
go back to reference Tseng JF, Kronowitz SJ, Sun CC, et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004;101(7):1514–23.CrossRefPubMed Tseng JF, Kronowitz SJ, Sun CC, et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004;101(7):1514–23.CrossRefPubMed
28.
go back to reference Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14(12):3328–34.CrossRefPubMed Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14(12):3328–34.CrossRefPubMed
29.
go back to reference McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol. 2005;23(22):5247–54.CrossRefPubMed McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol. 2005;23(22):5247–54.CrossRefPubMed
30.
31.
32.
go back to reference Lynce F, Graves KD, Jandorf L, et al. Genomic disparities in breast cancer among Latinas. Cancer Control J Moffitt Cancer Center. 2016;23(4):359–72.CrossRef Lynce F, Graves KD, Jandorf L, et al. Genomic disparities in breast cancer among Latinas. Cancer Control J Moffitt Cancer Center. 2016;23(4):359–72.CrossRef
33.
go back to reference Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999–2004. Breast J. 2009;15(6):593–602.CrossRefPubMed Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999–2004. Breast J. 2009;15(6):593–602.CrossRefPubMed
34.
go back to reference Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Women’s Health. 2011;20(10):1543–50.CrossRef Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Women’s Health. 2011;20(10):1543–50.CrossRef
35.
go back to reference Carvalho FM, Bacchi LM, Pincerato KM, Van de Rijn M, Bacchi CE. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Women’s Health. 2014;14:102.CrossRefPubMedPubMedCentral Carvalho FM, Bacchi LM, Pincerato KM, Van de Rijn M, Bacchi CE. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Women’s Health. 2014;14:102.CrossRefPubMedPubMedCentral
36.
go back to reference Fejerman L, Chen GK, Eng C, et al. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum Mol Genet. 2012;21(8):1907–17.CrossRefPubMedPubMedCentral Fejerman L, Chen GK, Eng C, et al. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum Mol Genet. 2012;21(8):1907–17.CrossRefPubMedPubMedCentral
37.
go back to reference Hines LM, Sedjo RL, Byers T, et al. The Interaction Between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic women: The Breast Cancer Health Disparities Study. Cancer Epidemiol Biomarkers Prev. 2016. Hines LM, Sedjo RL, Byers T, et al. The Interaction Between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic women: The Breast Cancer Health Disparities Study. Cancer Epidemiol Biomarkers Prev. 2016.
38.
go back to reference O’Malley C, Shema S, White E, Glaser S. Incidence of male breast cancer in california, 1988-2000: racial/ethnic variation in 1759 men. Breast Cancer Res Treat. 2005;93(2):145–50.CrossRefPubMed O’Malley C, Shema S, White E, Glaser S. Incidence of male breast cancer in california, 1988-2000: racial/ethnic variation in 1759 men. Breast Cancer Res Treat. 2005;93(2):145–50.CrossRefPubMed
40.
go back to reference Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed
41.
go back to reference Hershman D, Weinberg M, Rosner Z, et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst. 2003;95(20):1545–48.CrossRefPubMed Hershman D, Weinberg M, Rosner Z, et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst. 2003;95(20):1545–48.CrossRefPubMed
42.
go back to reference Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA. The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. Ann Surg Oncol. 2015;22(3):874–82.CrossRefPubMed Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA. The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. Ann Surg Oncol. 2015;22(3):874–82.CrossRefPubMed
43.
go back to reference Copson E, Maishman T, Gerty S, et al. Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer. 2014;110(1):230–41.CrossRefPubMed Copson E, Maishman T, Gerty S, et al. Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer. 2014;110(1):230–41.CrossRefPubMed
44.
45.
go back to reference Rapiti E, Pinaud K, Chappuis PO, et al. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study. Cancer Med. 2017;6(3):526–36.CrossRefPubMedPubMedCentral Rapiti E, Pinaud K, Chappuis PO, et al. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study. Cancer Med. 2017;6(3):526–36.CrossRefPubMedPubMedCentral
46.
47.
go back to reference Pal T, Permuth-Wey J, Holtje T, Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2004;13(11 Pt 1):1794–99.PubMed Pal T, Permuth-Wey J, Holtje T, Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2004;13(11 Pt 1):1794–99.PubMed
48.
go back to reference Akbari MR, Donenberg T, Lunn J, et al. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clin Genet. 2014;85(1):64–67.CrossRefPubMed Akbari MR, Donenberg T, Lunn J, et al. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clin Genet. 2014;85(1):64–67.CrossRefPubMed
49.
go back to reference Palmer JR, Ruiz-Narvaez EA, Rotimi CN, et al. Genetic susceptibility loci for subtypes of breast cancer in an African American population. Cancer Epidemiol Biomarkers Prev. 2013;22(1):127–34.CrossRefPubMed Palmer JR, Ruiz-Narvaez EA, Rotimi CN, et al. Genetic susceptibility loci for subtypes of breast cancer in an African American population. Cancer Epidemiol Biomarkers Prev. 2013;22(1):127–34.CrossRefPubMed
50.
go back to reference Haddad SA, Ruiz-Narvaez EA, Haiman CA, et al. (2016) An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium. Carcinogenesis 37(9):870–77.CrossRefPubMedPubMedCentral Haddad SA, Ruiz-Narvaez EA, Haiman CA, et al. (2016) An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium. Carcinogenesis 37(9):870–77.CrossRefPubMedPubMedCentral
52.
go back to reference Newman LA, Kaljee LM (2017) Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg 152(5):485–93.CrossRefPubMed Newman LA, Kaljee LM (2017) Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg 152(5):485–93.CrossRefPubMed
53.
go back to reference Jiagge E, Jibril AS, Chitale D, et al. (2016) Comparative analysis of breast cancer phenotypes in African American, white American, and West versus East African patients: correlation between African ancestry and triple-negative breast cancer. Ann Surg Oncol. 23(12):3843–49.CrossRefPubMed Jiagge E, Jibril AS, Chitale D, et al. (2016) Comparative analysis of breast cancer phenotypes in African American, white American, and West versus East African patients: correlation between African ancestry and triple-negative breast cancer. Ann Surg Oncol. 23(12):3843–49.CrossRefPubMed
54.
go back to reference Jemal A, Fedewa SA. Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than U.S.-born black women? Breast Cancer Res Treat. 2012;135(3):867–73.CrossRefPubMed Jemal A, Fedewa SA. Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than U.S.-born black women? Breast Cancer Res Treat. 2012;135(3):867–73.CrossRefPubMed
55.
go back to reference Ward BW, Clarke TC, Freeman GJ, Schiller JS. Early release of selected estimates based on data from the 2014 National Health Interview Survey. In: U.S.Department of Health and Human Services CfDCaP, National Center for Health Statistics, ed: DHHS; 2015. Ward BW, Clarke TC, Freeman GJ, Schiller JS. Early release of selected estimates based on data from the 2014 National Health Interview Survey. In: U.S.Department of Health and Human Services CfDCaP, National Center for Health Statistics, ed: DHHS; 2015.
56.
go back to reference U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2016. Available at: www.cdc.gov/uscs. Accessed 6 Sept 2016. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2016. Available at: www.​cdc.​gov/​uscs. Accessed 6 Sept 2016.
Metadata
Title
Breast Cancer Disparities: Socioeconomic Factors versus Biology
Author
Lisa A. Newman, MD, MPH
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5977-1

Other articles of this Issue 10/2017

Annals of Surgical Oncology 10/2017 Go to the issue